# Decreasing lifetime prevalence of diabetes-related foot ulcers in Norway: repeated cross-sectional population-based surveys from the HUNT study (1995-2019)

**Authors:** Hilde K. R. Riise, Jannicke Igland, Marit Graue, Anne Haugstvedt, Truls Østbye, Eirik Søfteland, Monica Hermann, Sofia Carlsson, Bjørn Olav Åsvold, Marjolein M. Iversen

PMC · DOI: 10.3389/fendo.2024.1354385 · 2024-04-17

## TL;DR

The study shows a significant decrease in diabetes-related foot ulcers in Norway from 1995 to 2019, across all age groups and diabetes types.

## Contribution

The study provides population-based evidence of a declining trend in DFU prevalence over nearly 25 years in Norway.

## Key findings

- Lifetime DFU prevalence decreased from 11.0% in 1995 to 5.3% in 2019.
- The decline was observed in both men and women, and for both type 1 and type 2 diabetes.
- Chronic kidney disease prevalence increased in individuals with and without DFU.

## Abstract

Diabetes-related foot ulcers (DFU) are a persistent healthcare challenge, impacting both patients and healthcare systems, with adverse effects on quality of life and productivity. Our primary aim was to examine the trends in lifetime prevalence of DFU, as well as other micro- and macrovascular complications in the Trøndelag Health Study (HUNT) in Norway.

This study consists of individuals ≥20 years with diabetes participating in the population-based cross-sectional HUNT surveys (1995-2019). Prevalence ratios, comparing the lifetime prevalence of DFU and other relevant micro- and macrovascular complications between the HUNT surveys, were calculated using Poisson regression.

The lifetime prevalence (95% confidence interval (CI)) of a DFU requiring three or more weeks to heal was 11.0% (9.5-12.7) in HUNT2, 7.5% (6.3-8.8) in HUNT3 and 5.3% (4.4-6.3) in HUNT4. The decrease in DFU prevalence from 1995 to 2019 was observed in both men and women, for all age groups, and for both type 1 and type 2 diabetes. The highest lifetime prevalence of DFU was found among those with type 1 diabetes. The decrease in HbA1c from HUNT2 to HUNT4 did not differ between those with and without a DFU. The prevalence of chronic kidney disease (eGFR <60 mL/min/1.73 m2 (eGFR categories G3-G5)) increased in both individuals with and without a DFU.

Results from the HUNT surveys show a substantial decline in the lifetime prevalence of DFU from 1995 to 2019.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** type 1 and type 2 diabetes (MESH:D003924), type 1 diabetes (MESH:D003922), DFU (MESH:D017719), foot ulcers (MESH:D016523), Diabetes (MESH:D003920), chronic kidney disease (MESH:D051436)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11061349/full.md

---
Source: https://tomesphere.com/paper/PMC11061349